#1 Source for Hair Loss and Propecia: Hair Loss Starters Guide - Propecia - Avodart - Rogaine - Nizoral
Special Hairloss Topics: Hair Transplant Advice - Hair Replacement Advice - Female Hair Loss
Revivogen
Ad: Revivogen
Regrowth.com

Hair Loss Study Abstract: The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.

Title
The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
Author
Dallob AL, Sadick NS, Unger W, Lipert S, Geissler LA, Gregoire SL, Nguyen HH, Moore EC, Tanaka WK
Address
Merck Research Laboratories, Rahway, New Jersey 07065.
Source
J Clin Endocrinol Metab, 79: 3, 1994 Sep, 703-6
Abstract
The effects of the 5 alpha-reductase inhibitor, finasteride, on scalp skin testosterone (T) and dihydrotestosterone (DHT) levels were studied in patients with male pattern baldness. In a double blind study, male patients undergoing hair transplantation were treated with oral finasteride (5 mg/day) or placebo for 28 days. Scalp skin biopsies were obtained before and after treatment for measurement of T and DHT by high pressure liquid chromatography-RIA. In 10 male subjects studied at baseline, mean (+/- SEM) DHT levels were significantly higher in bald (7.37 +/- 1.24 pmol/g) compared to hair-containing (4.20 +/- 0.65 pmol/g) scalp, whereas there was no difference in mean T levels at baseline. In bald scalp from 8 patients treated with finasteride, the mean DHT concentration decreased from 6.40 +/- 1.07 pmol/g at baseline to 3.62 +/- 0.38 pmol/g on day 28. Scalp T levels increased in 6 of 8 subjects treated with finasteride. Finasteride decreased the mean serum DHT concentration from 1.36 +/- 0.18 nmol/L (n = 8) at baseline to 0.46 +/- 0.10 nmol/L on day 28 and had no effect on serum T. There were no significant changes in scalp or serum T or DHT in placebo-treated patients. In this study, male subjects treated with 5 mg/day finasteride for 4 weeks had significantly decreased concentrations of DHT in bald scalp, resulting in a mean level similar to the baseline levels found in hair-containing scalp.
Language of Publication
English
Unique Identifier
94358066
content2

Location:
Unknown

Location wrong? Click here
What's This?

Web
regrowth.com
Re-Mox 5% Minoxidil Combination Therapy
Ad: Re-Mox 5% Minoxidil Combination Therapy

More Info: Home | About Regrowth.com | How to Advertise | Privacy Policy | Advertising Policy | Contact Us
Site Map | Copyright © 2007 The Regrowth Network. All rights reserved. Legal Disclaimer

Other Cool Sites: Hair Loss Treatments - Body for Life Tracker - MedSpert

Propecia ® is a registered trademark of Merck. Avodart ® is a registered trademark of GlaxoSmithKline.
Rogaine ® is a registered trademark of Pfizer. Nizoral ® is a registered trademark of McNeil Consumer & Specialty Pharmaceuticals.